UBS Group’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.7M | Buy |
|
|||||
|
2025
Q2 | $3.4M | Sell |
|
|||||
|
2025
Q1 | $3.71M | Buy |
|
|||||
|
2024
Q4 | $3.08M | Buy |
|
|||||
|
2024
Q3 | $319K | Buy |
|
|||||
|
2024
Q2 | $159K | Sell |
|
|||||
|
2024
Q1 | $262K | Sell |
|
|||||
|
2023
Q4 | $242K | Buy |
|
|||||
|
2023
Q3 | $115K | Sell |
|
|||||
|
2023
Q2 | $164K | Buy |
|
|||||
|
2023
Q1 | $11.9K | Buy |
|
|||||
|
2022
Q4 | $3.92K | Sell |
|
|||||
|
2022
Q3 | $22K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $56K | Sell |
|
|||||
|
2021
Q4 | $83K | Buy |
|
|||||
|
2021
Q3 | $22K | Buy |
|
|||||
|
2021
Q2 | $7K | Sell |
|
|||||
|
2021
Q1 | $97K | Buy |
|
|||||
|
2020
Q4 | $54K | Buy |
|
|||||
|
2020
Q3 | $24K | Sell |
|
|||||
|
2020
Q2 | $63K | Sell |
|
|||||
|
2020
Q1 | $55K | Sell |
|
|||||
|
2019
Q4 | $230K | Buy |
|
|||||
|
2019
Q3 | $116K | Buy |
|
|||||
|
2019
Q2 | $55K | Buy |
|
|||||
|
2019
Q1 | $11K | Buy |
|
|||||
|
2018
Q4 | $1K | Hold |
|
|||||
|
2018
Q3 | $1K | Hold |
|
|||||
|
2018
Q2 | $0 | Sell |
|
|||||
|
2018
Q1 | $5K | Sell |
|
|||||
|
2017
Q4 | $32K | Buy |
|
|||||
|
2017
Q3 | $1K | Sell |
|
|||||
|
2017
Q2 | $8K | Sell |
|
|||||
|
2017
Q1 | $39K | Sell |
|
|||||
|
2016
Q4 | $39K | Sell |
|
|||||
|
2016
Q3 | $85K | Buy |
|
|||||
|
2016
Q2 | $63K | Buy |
|
|||||
|
2016
Q1 | $83K | Sell |
|
|||||
|
2015
Q4 | $251K | Sell |
|
|||||
|
2015
Q3 | $329K | Sell |
|
|||||
|
2015
Q2 | $808K | Buy |
|
|||||
|
2015
Q1 | $1.9M | Buy |
|